Healthcare Triangle, Inc.

For the period ended Mar 31, 2026. Filed May 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

HCTI$4.21-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Condensed Consolidated Balance sheets

Condensed Consolidated Balance Sheets

March 31, · December 31,
	Note	2026	2025
(Unaudited) · (Audited)
Assets
Current assets
Cash and cash equivalents		$4,315	$7,625
Accounts receivable, net	3	8,367	2,070
Advances	8	3,826	3,826
Other current assets	4	2,387	3,456
Total current assets		18,895	16,977
Furniture and equipment, net	6	1,330	5
Other intangible assets, net	5	55,219	2,808
Goodwill	5	2,946	2,946
Operating lease right-of-use assets	7	1,166	-
Other non-current assets		204	-
Deferred tax asset		402	-
Total assets		$80,162	$22,736
Liabilities and stockholders’ equity
Current liabilities
Accounts payable		$3,288	$744
Short-term borrowing	9	9,088	10,737
Operating lease liabilities	7	454	-
Other current liabilities	10	8,163	1,311
Total current liabilities		20,993	12,792
Long term liabilities
Long term debt	9	629	-
Operating long-term lease liabilities	7	700	-
Contingent consideration	11	5,000	-
Other long-term liabilities		143	-
Total current and long-term liabilities		27,465	12,792
Stockholders’ equity	12
Preferred Stock, par value $0.00001; 10,000,000 authorized
Series A, Super Voting Preferred Stock - 20,000 shares (1,000 votes per share) issued and outstanding as of March 31, 2026, and December 31, 2025, respectively		-	-
Series B Convertible preferred stock, 107 issued and outstanding as of March 31, 2026, and December 31, 2025, respectively		7,435	7,435
Series C Convertible preferred stock (to be issued)		18,000	-
Common stock, par value $0.00001; 2,000,000,000 authorized, 1,846,424 and 142,426 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively		11	11
Non-controlling interest		(61)	(37)
Additional paid-in capital		76,651	45,534
Accumulated deficit		(49,339)	(42,999)
Total stockholders’ equity		52,697	9,944
Total liabilities and stockholders’ equity		$80,162	$22,736

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.